EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.
暂无分享,去创建一个
T. Schwartz | M. Rosenkilde | Kristoffer L Egerod | J. Christensen | A. Kovalchuk | Hongsheng Wang | H. Morse | A. Thomsen | P. Holst | M. R. Bassi | Viktorija Daugvilaite | V. Kubale | T. Benned-Jensen | L. Barington | Katja Spiess | K. Niss Arfelt | Kristoffer L. Egerod | Line Barington
[1] G. Basso,et al. Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins , 2016, Journal of leukocyte biology.
[2] K. Haas. B‐1 lymphocytes in mice and nonhuman primates , 2015, Annals of the New York Academy of Sciences.
[3] A. Kittai,et al. Chronic Lymphocytic Leukemia: Current Concepts. , 2015, Anticancer research.
[4] Imogen Moran,et al. T follicular helper cells have distinct modes of migration and molecular signatures in naive and memory immune responses. , 2015, Immunity.
[5] U. Klein,et al. Mouse models in the study of chronic lymphocytic leukemia pathogenesis and therapy. , 2014, Blood.
[6] M. Rosenkilde,et al. Oxysterol-EBI2 signaling in immune regulation and viral infection , 2014, European journal of immunology.
[7] K. Seuwen,et al. Transcriptional regulation and functional characterization of the oxysterol/EBI2 system in primary human macrophages. , 2014, Biochemical and biophysical research communications.
[8] S. Joshi,et al. Accelerated Development of Chronic Lymphocytic Leukemia in New Zealand Black Mice Expressing a Low Level of Interferon Regulatory Factor 4* , 2013, The Journal of Biological Chemistry.
[9] F. Schuit,et al. Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype. , 2013, Blood.
[10] J. Cyster,et al. EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture , 2013, eLife.
[11] G. Karupiah,et al. The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells , 2013, Nature Immunology.
[12] M. Rosenkilde,et al. Small molecule antagonism of oxysterol-induced Epstein–Barr virus induced gene 2 (EBI2) activation☆ , 2013, FEBS open bio.
[13] T. Lovenberg,et al. Identification of Structural Motifs Critical for Epstein-Barr Virus-Induced Molecule 2 Function and Homology Modeling of the Ligand Docking Site , 2012, Molecular Pharmacology.
[14] J. Gustafsson,et al. Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. , 2012, Immunity.
[15] T. Frimurer,et al. Molecular Characterization of Oxysterol Binding to the Epstein-Barr Virus-induced Gene 2 (GPR183)* , 2012, The Journal of Biological Chemistry.
[16] J. Kutok,et al. Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model , 2012, Cell.
[17] L. Karlsson,et al. Oxysterols direct B-cell migration through EBI2 , 2011, Nature.
[18] P. Schultz,et al. Oxysterols direct immune cell migration via EBI2 , 2011, Nature.
[19] Y. Mori,et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. , 2011, Immunity.
[20] T. Schwartz,et al. Ligand Modulation of the Epstein-Barr Virus-induced Seven-transmembrane Receptor EBI2 , 2011, The Journal of Biological Chemistry.
[21] T. Rothstein,et al. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70− , 2011, The Journal of experimental medicine.
[22] N. Baumgarth. The double life of a B-1 cell: self-reactivity selects for protective effector functions , 2011, Nature Reviews Immunology.
[23] Albert Gutierrez,et al. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. , 2010, Blood.
[24] Martin Vingron,et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk , 2010, Nature.
[25] Margarida Saraiva,et al. The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.
[26] C. Mackay,et al. Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. , 2009, Immunity.
[27] G Brockhoff,et al. Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles , 2009, Leukemia.
[28] J. Cyster,et al. EBV induced molecule-2 mediates B cell segregation between outer and center follicle , 2009, Nature.
[29] Lawrence R. Johnson,et al. Gene Expression Profiling of Epstein-Barr Virus-positive and -negative Monomorphic B-cell Posttransplant Lymphoproliferative Disorders , 2007, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[30] J. Miguel,et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals , 2007, Leukemia.
[31] Randall S. Davis,et al. Fc Receptor Homolog 3 Is a Novel Immunoregulatory Marker of Marginal Zone and B1 B Cells1 , 2006, The Journal of Immunology.
[32] Rob Leurs,et al. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis , 2006, Proceedings of the National Academy of Sciences.
[33] T. Schwartz,et al. Molecular Pharmacological Phenotyping of EBI2 , 2006, Journal of Biological Chemistry.
[34] G. Gahrton,et al. Identification of progression markers in B-CLL by gene expression profiling. , 2005, Experimental hematology.
[35] L. Boxer,et al. Regulatory Elements in the Immunoglobulin Heavy Chain Gene 3′-Enhancers Induce c-myc Deregulation and Lymphomagenesis in Murine B Cells* , 2005, Journal of Biological Chemistry.
[36] G. Bismuth,et al. Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. , 2002, Blood.
[37] C. Croce,et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[38] T. Schwartz,et al. Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. , 2001, The Journal of clinical investigation.
[39] J. Kearney,et al. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.
[40] T. Honjo,et al. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme , 2000, Cell.
[41] E. Cesarman,et al. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator , 1998, Nature.
[42] P. Kourilsky,et al. Clonal expansions of B lymphocytes in old mice. , 1997, Journal of immunology.
[43] A. Strasser,et al. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice , 1994, Nature.
[44] E. Kieff,et al. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors , 1993, Journal of virology.
[45] M. Howard,et al. Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10 , 1992, European journal of immunology.
[46] K. Rajewsky,et al. Expression of IgH promoter/enhancer Ly-1 transgene in hematopoietic chimeric mice generated by embryonic stem cell line. , 1990, International archives of allergy and applied immunology.